Molecular pathophysiology of Parkinson's disease

被引:963
|
作者
Moore, DJ [1 ]
West, AB
Dawson, VL
Dawson, TM
机构
[1] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA
关键词
alpha-synuclein; parkin; mitochondrial complex-I; ubiquitin-proteasome system; oxidative stress;
D O I
10.1146/annurev.neuro.28.061604.135718
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that results primarily from the death of dopaminergic neurons in the substantia nigra. Although the etiology of PD is incompletely understood, the recent discovery of genes associated with rare monogenic forms of the disease, together with earlier studies and new experimental animal models, has provided important and novel insight into the molecular pathways involved in disease pathogenesis. Increasing evidence indicates that deficits in mitochondrial function, oxidative and nitrosative stress, the accumulation of aberrant or misfolded proteins, and ubiquitin-proteasome system dysfunction may represent the principal molecular pathways or events that commonly underlie the pathogenesis of sporadic and familial forms of PD.
引用
收藏
页码:57 / 87
页数:31
相关论文
共 50 条
  • [1] Cellular and molecular pathophysiology in the progression of Parkinson’s disease
    Vandana Zaman
    Donald C. Shields
    Ramsha Shams
    Kelsey P. Drasites
    Denise Matzelle
    Azizul Haque
    Narendra L. Banik
    Metabolic Brain Disease, 2021, 36 : 815 - 827
  • [2] Cellular and molecular pathophysiology in the progression of Parkinson's disease
    Zaman, Vandana
    Shields, Donald C.
    Shams, Ramsha
    Drasites, Kelsey P.
    Matzelle, Denise
    Haque, Azizul
    Banik, Narendra L.
    METABOLIC BRAIN DISEASE, 2021, 36 (05) : 815 - 827
  • [3] Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson's Disease
    Angelopoulou, Efthalia
    Bougea, Anastasia
    Paudel, Yam Nath
    Georgakopoulou, Vasiliki Epameinondas
    Papageorgiou, Sokratis G. G.
    Piperi, Christina
    MEDICINA-LITHUANIA, 2023, 59 (06):
  • [4] Pathophysiology of Parkinson's disease
    Mandir, AS
    Vaughan, C
    INTERNATIONAL REVIEW OF PSYCHIATRY, 2000, 12 (04) : 270 - 280
  • [5] Pathophysiology of Parkinson's disease
    Bonnet, AM
    Houeto, JL
    BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (03) : 117 - 121
  • [6] Parkinson's Disease Genetics and Pathophysiology
    Vazquez-Velez, Gabriel E.
    Zoghbi, Huda Y.
    ANNUAL REVIEW OF NEUROSCIENCE, VOL 44, 2021, 2021, 44 : 87 - 108
  • [7] The pathophysiology of Parkinson's disease tremor
    Dirkx, Michiel F.
    Bologna, Matteo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 435
  • [8] Pathophysiology and treatment on Parkinson's disease
    Shimohama, Shun
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2005, 125 : 64 - 67
  • [9] Pathophysiology of Parkinson's disease: an update
    Tremblay, Leon
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2010, 194 (07): : 1321 - 1331
  • [10] Physiology and pathophysiology of Parkinson's disease
    Hamani, C
    Lozano, AM
    PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON, 2003, 991 : 15 - 21